{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:14:18Z","timestamp":1783548858127,"version":"3.55.0"},"reference-count":192,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Non-coding RNA Research"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ncrna.2023.04.001","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T04:23:20Z","timestamp":1684211000000},"page":"426-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Non-coding RNA-mediated epigenetic alterations in Grave's ophthalmopathy: A scoping systematic review"],"prefix":"10.1016","volume":"8","author":[{"given":"Kourosh","family":"Shahraki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vida Ilkhani","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kianoush","family":"Shahraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paria Ghasemi","family":"Boroumand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7996-845X","authenticated-orcid":false,"given":"Roghayeh","family":"Sheervalilou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ncrna.2023.04.001_bib1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1210\/er.2018-00066","article-title":"Insulin-like growth factor-I receptor and thyroid-associated ophthalmopathy","volume":"40","author":"Smith","year":"2019","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/j.ncrna.2023.04.001_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1089\/thy.2018.0665","article-title":"Knowledge of thyroid eye disease in graves' disease patients with and without orbitopathy","volume":"29","author":"Edmunds","year":"2019","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.ncrna.2023.04.001_bib3","first-page":"40","article-title":"Clinical and topographical corneal changes after Keraring implantation in keratoconus patients","volume":"3","author":"Mohamad","year":"2015","journal-title":"Adv. Biosci. Clin. Med."},{"issue":"2","key":"10.1016\/j.ncrna.2023.04.001_bib4","first-page":"185","article-title":"Graves' disease","volume":"376","author":"Smith","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ncrna.2023.04.001_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.beem.2011.10.003","article-title":"Immunopathogenesis of Graves' ophthalmopathy: the role of the TSH receptor","volume":"26","author":"Iyer","year":"2012","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"issue":"3","key":"10.1016\/j.ncrna.2023.04.001_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pathophys.2017.05.005","article-title":"Interleukin-6 participation in pathology of ocular diseases","volume":"24","author":"Zahir-Jouzdani","year":"2017","journal-title":"Pathophysiology"},{"key":"10.1016\/j.ncrna.2023.04.001_bib7","first-page":"417","article-title":"Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role?","volume":"4","author":"Lahooti","year":"2010","journal-title":"Clin. Ophthalmol."},{"issue":"10","key":"10.1016\/j.ncrna.2023.04.001_bib8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1055\/s-0035-1555762","article-title":"Current insights into the pathogenesis of graves' ophthalmopathy","volume":"47","author":"Bahn","year":"2015","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ncrna.2023.04.001_bib9","first-page":"2271","article-title":"Does autoimmunity against thyroglobulin play a role in the pathogenesis of Graves' ophthalmopathy: a review","volume":"9","author":"Shanmuganathan","year":"2015","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ncrna.2023.04.001_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7453260","article-title":"Immunological aspects of graves' ophthalmopathy","volume":"2019","author":"\u0141acheta","year":"2019","journal-title":"BioMed Res. Int."},{"issue":"11","key":"10.1016\/j.ncrna.2023.04.001_bib11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrm3890","article-title":"Histone core modifications regulating nucleosome structure and dynamics","volume":"15","author":"Tessarz","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.ncrna.2023.04.001_bib12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ncrna.2023.04.001_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"issue":"21","key":"10.1016\/j.ncrna.2023.04.001_bib14","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMra023075","article-title":"Gene silencing in cancer in association with promoter hypermethylation","volume":"349","author":"Herman","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.ncrna.2023.04.001_bib15","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJMra072067","article-title":"Epigenetics in cancer","volume":"358","author":"Esteller","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ncrna.2023.04.001_bib16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrg.2016.93","article-title":"Targeting the cancer epigenome for therapy","volume":"17","author":"Jones","year":"2016","journal-title":"Nat. Rev. Genet."},{"issue":"9","key":"10.1016\/j.ncrna.2023.04.001_bib17","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.18240\/ijo.2021.09.22","article-title":"Epigenetics effect on pathogenesis of thyroid-associated ophthalmopathy","volume":"14","author":"Cao","year":"2021","journal-title":"Int. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.ncrna.2023.04.001_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.ncrna.2023.04.001_bib19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41571-018-0004-4","article-title":"Analysis of DNA methylation in cancer: location revisited","volume":"15","author":"Koch","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ncrna.2023.04.001_bib20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41580-019-0143-1","article-title":"The roles of DNA, RNA and histone methylation in ageing and cancer","volume":"20","author":"Michalak","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7271","key":"10.1016\/j.ncrna.2023.04.001_bib21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature08514","article-title":"Human DNA methylomes at base resolution show widespread epigenomic differences","volume":"462","author":"Lister","year":"2009","journal-title":"Nature"},{"issue":"7643","key":"10.1016\/j.ncrna.2023.04.001_bib22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nature21373","article-title":"Intragenic DNA methylation prevents spurious transcription initiation","volume":"543","author":"Neri","year":"2017","journal-title":"Nature"},{"issue":"7303","key":"10.1016\/j.ncrna.2023.04.001_bib23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nature09165","article-title":"Conserved role of intragenic DNA methylation in regulating alternative promoters","volume":"466","author":"Maunakea","year":"2010","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ncrna.2023.04.001_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/07435800.2021.1914079","article-title":"Relationship between functional miR-143\/145 cluster variants and susceptibility to type 2 diabetes mellitus: a preliminary case-control study and bioinformatics analyses","volume":"46","author":"Jahantigh","year":"2021","journal-title":"Endocr. Res."},{"key":"10.1016\/j.ncrna.2023.04.001_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119489","article-title":"Chitosan nanocarriers for microRNA delivery and detection: a preliminary review with emphasis on cancer","author":"Sargazi","year":"2022","journal-title":"Carbohydrate Polym."},{"key":"10.1016\/j.ncrna.2023.04.001_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104544","article-title":"An updated overview and classification of bioinformatics tools for MicroRNA analysis, which one to choose?","volume":"134","author":"Mortazavi","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.ncrna.2023.04.001_bib27","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s40200-020-00670-6","article-title":"Swimming training attenuates pancreatic apoptosis through miR-34a\/Sirtu in1\/P53 Axis in high-fat diet and Streptozotocin-induced Type-2 diabetic rats","volume":"19","author":"Alipour","year":"2020","journal-title":"J. Diabetes Metab. Disord."},{"issue":"15","key":"10.1016\/j.ncrna.2023.04.001_bib28","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.3805","article-title":"miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies","volume":"6","author":"Amodio","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ncrna.2023.04.001_bib29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/CIRCRESAHA.114.305490","article-title":"Dawn of the epi-LncRNAs: new path from myheart","volume":"116","author":"Wang","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.ncrna.2023.04.001_bib30","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijbiomac.2022.02.082","article-title":"Opportunities and challenges of using high-sensitivity nanobiosensors to detect long noncoding RNAs: a preliminary review","volume":"205","author":"Sargazi","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ncrna.2023.04.001_bib31","first-page":"1","article-title":"Prevalence of miR146a gene polymorphisms in diabetic and non-diabetic patients with chronic kidney disease","author":"Sargazi","year":"2022","journal-title":"Iran. J. Sci. Technol. Trans. A-Science"},{"key":"10.1016\/j.ncrna.2023.04.001_bib32","first-page":"77","article-title":"Chapter 4 - epigenetic mechanisms in the regulation of lymphocyte differentiation","volume":"vol. 16","author":"Schmolka","year":"2020"},{"key":"10.1016\/j.ncrna.2023.04.001_bib33","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.biopha.2017.02.002","article-title":"Using miR-10b, miR-1 and miR-30a expression profiles of bronchoalveolar lavage and sputum for early detection of non-small cell lung cancer","volume":"88","author":"Sheervalilou","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.ncrna.2023.04.001_bib34","first-page":"118","article-title":"Circulating MiR-10b, MiR-1 and MiR-30a expression profiles in lung cancer: possible correlation with clinico-pathologic characteristics and lung cancer detection","volume":"8","author":"Sheervalilou","year":"2019","journal-title":"Int. J. Mol. Cell. Med."},{"issue":"3","key":"10.1016\/j.ncrna.2023.04.001_bib35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ceb.2012.03.006","article-title":"Small non-coding RNAs mount a silent revolution in gene expression","volume":"24","author":"Aalto","year":"2012","journal-title":"Curr. Opin. Cell Biol."},{"issue":"7228","key":"10.1016\/j.ncrna.2023.04.001_bib36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nature07755","article-title":"A three-dimensional view of the molecular machinery of RNA interference","volume":"457","author":"Jinek","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ncrna.2023.04.001_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1566524019666191001114941","article-title":"Electrochemical nano-biosensors as novel approach for the detection of lung cancer-related MicroRNAs","volume":"20","author":"Sheervalilou","year":"2020","journal-title":"Curr. Mol. Med."},{"issue":"16","key":"10.1016\/j.ncrna.2023.04.001_bib38","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1093\/nar\/gkh824","article-title":"Structural requirements for pre-microRNA binding and nuclear export by Exportin 5","volume":"32","author":"Zeng","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ncrna.2023.04.001_bib39","article-title":"Functional miR29a gene polymorphism enhanced the risk of chronic kidney disease in an Iranian population: a preliminary case-control study and bioinformatics analyses","volume":"25","author":"Sargazi","year":"2020","journal-title":"Meta Gene"},{"issue":"7","key":"10.1016\/j.ncrna.2023.04.001_bib40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrg3462","article-title":"Argonaute proteins: functional insights and emerging roles","volume":"14","author":"Meister","year":"2013","journal-title":"Nat. Rev. Genet."},{"issue":"7228","key":"10.1016\/j.ncrna.2023.04.001_bib41","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature07756","article-title":"Small RNAs in transcriptional gene silencing and genome defence","volume":"457","author":"Moazed","year":"2009","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ncrna.2023.04.001_bib42","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/wrna.80","article-title":"RITS\u2014connecting transcription, RNA interference, and heterochromatin assembly in fission yeast","volume":"2","author":"Creamer","year":"2011","journal-title":"WIREs RNA"},{"issue":"7308","key":"10.1016\/j.ncrna.2023.04.001_bib43","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nature09267","article-title":"Mammalian microRNAs predominantly act to decrease target mRNA levels","volume":"466","author":"Guo","year":"2010","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ncrna.2023.04.001_bib44","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.3192","article-title":"The landscape of long noncoding RNAs in the human transcriptome","volume":"47","author":"Iyer","year":"2015","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.ncrna.2023.04.001_bib45","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1101\/gr.132159.111","article-title":"The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression","volume":"22","author":"Derrien","year":"2012","journal-title":"Genome Res."},{"issue":"6113","key":"10.1016\/j.ncrna.2023.04.001_bib46","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1126\/science.1231776","article-title":"Epigenetic regulation by long noncoding RNAs","volume":"338","author":"Lee","year":"2012","journal-title":"Science"},{"issue":"18","key":"10.1016\/j.ncrna.2023.04.001_bib47","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1101\/gad.17446611","article-title":"Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses","volume":"25","author":"Cabili","year":"2011","journal-title":"Genes Dev."},{"issue":"10","key":"10.1016\/j.ncrna.2023.04.001_bib48","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nrg.2016.85","article-title":"Evolution to the rescue: using comparative genomics to understand long non-coding RNAs","volume":"17","author":"Ulitsky","year":"2016","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.ncrna.2023.04.001_bib49","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13059-017-1348-2","article-title":"The multidimensional mechanisms of long noncoding RNA function","volume":"18","author":"Marchese","year":"2017","journal-title":"Genome Biol."},{"key":"10.1016\/j.ncrna.2023.04.001_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.742242","article-title":"Molecular insight into the therapeutic potential of long non-coding RNA-associated competing endogenous RNA axes in Alzheimer's disease: a systematic scoping review","volume":"13","author":"Sabaie","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"7","key":"10.1016\/j.ncrna.2023.04.001_bib51","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41585-018-0023-z","article-title":"Epigenetics in renal cell cancer: mechanisms and clinical applications","volume":"15","author":"Joosten","year":"2018","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"10.1016\/j.ncrna.2023.04.001_bib52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int. J. Soc. Res. Methodol."},{"key":"10.1016\/j.ncrna.2023.04.001_bib53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1748-5908-5-69","article-title":"Scoping studies: advancing the methodology","volume":"5","author":"Levac","year":"2010","journal-title":"Implement. Sci."},{"issue":"7","key":"10.1016\/j.ncrna.2023.04.001_bib54","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ncrna.2023.04.001_bib55","doi-asserted-by":"crossref","first-page":"639","DOI":"10.12659\/MSM.890686","article-title":"Increased microRNA-155 and decreased microRNA-146a may promote ocular inflammation and proliferation in Graves' ophthalmopathy","volume":"20","author":"Li","year":"2014","journal-title":"Med. Sci. Mon."},{"issue":"15","key":"10.1016\/j.ncrna.2023.04.001_bib56","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1167\/iovs.16-20559","article-title":"Role of miR-146a in the regulation of inflammation in an in vitro model of graves' orbitopathy","volume":"57","author":"Wang","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"15","key":"10.1016\/j.ncrna.2023.04.001_bib57","doi-asserted-by":"crossref","first-page":"6796","DOI":"10.1167\/iovs.16-20847","article-title":"Author response: role of miR-146a in the regulation of inflammation in an in vitro model of graves' orbitopathy","volume":"57","author":"Jang","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3\u20134","key":"10.1016\/j.ncrna.2023.04.001_bib58","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000453618","article-title":"The efficacy of rituximab combined with 131I for ophthalmic outcomes of graves' ophthalmopathy patients","volume":"99","author":"Li","year":"2017","journal-title":"Pharmacology"},{"issue":"4","key":"10.1016\/j.ncrna.2023.04.001_bib59","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1159\/000464430","article-title":"Mechanism of MicroRNA-146a\/Notch2 signa ng regulating IL-6 in graves ophthalmopathy","volume":"41","author":"Wang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ncrna.2023.04.001_bib60","article-title":"Circulating miRNA-21-5p role in the development of orbitopathy in Graves disease","volume":"20","author":"Al-Heety","year":"2020","journal-title":"Gene Rep."},{"issue":"1","key":"10.1016\/j.ncrna.2023.04.001_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010153","article-title":"MiR-199a downregulation as a driver of the NOX4\/HIF-1\u03b1\/VEGF-a pathway in thyroid and orbital adipose tissues from graves' patients","volume":"23","author":"Craps","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ncrna.2023.04.001_bib62","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1167\/iovs.62.1.29","article-title":"MicroRNA-130a is elevated in thyroid eye disease and increases lipid accumulation in fibroblasts through the suppression of AMPK","volume":"62","author":"Hammond","year":"2021","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.ncrna.2023.04.001_bib63","first-page":"1803","article-title":"Decreased microRNA-146a in CD4+T cells promote ocular inflammation in thyroid-associated ophthalmopathy by targeting NUMB","volume":"21","author":"Hu","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.ncrna.2023.04.001_bib64","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1167\/iovs.16-19213","article-title":"Role of miR-146a in the regulation of inflammation in an in vitro model of graves' orbitopathy","volume":"57","author":"Jang","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.ncrna.2023.04.001_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221077","article-title":"MicroRNA-27 inhibits adipogenic differentiation in orbital fibroblasts from patients with Graves' orbitopathy","volume":"14","author":"Jang","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ncrna.2023.04.001_bib66","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/bjophthalmol-2017-310723","article-title":"Role of microRNA-146a in regulation of fibrosis in orbital fibroblasts from patients with Graves' orbitopathy","volume":"102","author":"Jang","year":"2018","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.ncrna.2023.04.001_bib67","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1167\/iovs.15-18157","article-title":"PDGF-BB enhances the proliferation of cells in human orbital fibroblasts by suppressing PDCD4 expression via up-regulation of microRNA-21","volume":"57","author":"Lee","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.ncrna.2023.04.001_bib68","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2020.9165","article-title":"MicroRNA-146a downregulates the production of hyaluronic acid and collagen I in Graves' ophthalmopathy orbital fibroblasts","volume":"20","author":"Liu","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"2","key":"10.1016\/j.ncrna.2023.04.001_bib69","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12020-014-0487-4","article-title":"Circulating microRNA predicts insensitivity to glucocorticoid therapy in Graves' ophthalmopathy","volume":"49","author":"Shen","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.ncrna.2023.04.001_bib70","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaut.2018.08.010","article-title":"MicroRNA-183 and microRNA-96 are associated with autoimmune responses by regulating T cell activation","volume":"96","author":"Thiel","year":"2019","journal-title":"J. Autoimmun."},{"issue":"8","key":"10.1016\/j.ncrna.2023.04.001_bib71","doi-asserted-by":"crossref","first-page":"E2866","DOI":"10.1210\/clinem\/dgab256","article-title":"LncRNA LPAL2\/miR-1287-5p\/EGFR Axis modulates TED-derived orbital fibroblast activation through cell adhesion factors","volume":"106","author":"Wang","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.ncrna.2023.04.001_bib72","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1507\/endocrj.EJ14-0246","article-title":"Circulating levels of miR-146a and IL-17 are significantly correlated with the clinical activity of graves' ophthalmopathy","volume":"61","author":"Wei","year":"2014","journal-title":"Endocr. J."},{"issue":"13","key":"10.1016\/j.ncrna.2023.04.001_bib73","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1167\/iovs.19-27865","article-title":"TSHR signaling stimulates proliferation through PI3K\/Akt and induction of miR-146a and miR-155 in thyroid eye disease orbital fibroblasts","volume":"60","author":"Woeller","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1 Pt 2","key":"10.1016\/j.ncrna.2023.04.001_bib74","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ygeno.2020.09.001","article-title":"Identification of differentially expressed long non-coding RNAs and mRNAs in orbital adipose\/connective tissue of thyroid-associated ophthalmopathy","volume":"113","author":"Wu","year":"2021","journal-title":"Genomics"},{"issue":"4","key":"10.1016\/j.ncrna.2023.04.001_bib75","first-page":"1801","article-title":"MicroRNA-146a contributes to CD4(+) T lymphocyte differentiation in patients with thyroid ophthalmopathy","volume":"9","author":"Yang","year":"2017","journal-title":"Am. J. Tourism Res."},{"key":"10.1016\/j.ncrna.2023.04.001_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.795546","article-title":"A novel competing endogenous RNA network associated with the pathogenesis of graves' ophthalmopathy","volume":"12","author":"Yue","year":"2021","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.ncrna.2023.04.001_bib77","doi-asserted-by":"crossref","first-page":"8386","DOI":"10.1038\/s41598-018-26700-1","article-title":"Combining micro-RNA and protein sequencing to detect robust biomarkers for Graves' disease and orbitopathy","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ncrna.2023.04.001_bib78","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ebiom.2019.10.061","article-title":"Integrated miRNA and mRNA expression profiling identifies novel targets and pathological mechanisms in autoimmune thyroid diseases","volume":"50","author":"Mart\u00ednez-Hern\u00e1ndez","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ncrna.2023.04.001_bib79","first-page":"324","article-title":"MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy","volume":"21","author":"Tong","year":"2015","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ncrna.2023.04.001_bib80","first-page":"2022","article-title":"Association of polymorphisms in miR146a, an inflammation-associated MicroRNA, with the risk of idiopathic recurrent spontaneous miscarriage: a case-control study","author":"Salimi","year":"2022","journal-title":"Dis. Markers"},{"issue":"1","key":"10.1016\/j.ncrna.2023.04.001_bib81","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40995-021-01229-7","article-title":"Prevalence of miR146a gene polymorphisms in diabetic and non-diabetic patients with chronic kidney disease","volume":"46","author":"Sargazi","year":"2022","journal-title":"Iran. J. Sci. Technol. Trans. A-Science"},{"issue":"6","key":"10.1016\/j.ncrna.2023.04.001_bib82","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3109\/08830180903208303","article-title":"microRNAs in inflammation","volume":"28","author":"Sonkoly","year":"2009","journal-title":"Int. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.ncrna.2023.04.001_bib83","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s10753-012-9467-0","article-title":"Association of MicroRNA-146a with autoimmune diseases","volume":"35","author":"Xu","year":"2012","journal-title":"Inflammation"},{"issue":"9","key":"10.1016\/j.ncrna.2023.04.001_bib84","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.autrev.2010.05.009","article-title":"MicroRNAs in Sj\u00f6gren's syndrome as a prototypic autoimmune disease","volume":"9","author":"Alevizos","year":"2010","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.ncrna.2023.04.001_bib85","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/art.23429","article-title":"Expression of microRNA-146 in rheumatoid arthritis synovial tissue","volume":"58","author":"Nakasa","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.ncrna.2023.04.001_bib86","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/art.23386","article-title":"Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis","volume":"58","author":"Stanczyk","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.ncrna.2023.04.001_bib87","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/art.24404","article-title":"Expression of MicroRNA-146a in osteoarthritis cartilage","volume":"60","author":"Yamasaki","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.ncrna.2023.04.001_bib88","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.24436","article-title":"MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins","volume":"60","author":"Tang","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.ncrna.2023.04.001_bib89","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0092-8674(89)90849-0","article-title":"numb, a gene required in determination of cell fate during sensory organ formation in Drosophila embryos","volume":"58","author":"Uemura","year":"1989","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ncrna.2023.04.001_bib90","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","article-title":"A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?","volume":"146","author":"Salmena","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ncrna.2023.04.001_bib91","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3389\/fnmol.2018.00370","article-title":"Competing endogenous RNA regulations in neurodegenerative disorders: current challenges and emerging insights","volume":"11","author":"Cai","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ncrna.2023.04.001_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.742242","article-title":"Molecular insight into the therapeutic potential of long non-coding RNA-associated competing endogenous RNA axes in Alzheimer's disease: a systematic scoping review","volume":"13","author":"Sabaie","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"12","key":"10.1016\/j.ncrna.2023.04.001_bib93","doi-asserted-by":"crossref","first-page":"13479","DOI":"10.18632\/oncotarget.7266","article-title":"Competing endogenous RNA networks in human cancer: hypothesis, validation, and perspectives","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ncrna.2023.04.001_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.754296","article-title":"Mechanistic insight into the regulation of immune-related genes expression in autism spectrum disorder","volume":"8","author":"Sabaie","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.ncrna.2023.04.001_bib95","article-title":"Long non-coding RNA-associated competing endogenous RNA axes in the olfactory epithelium in schizophrenia: a bioinformatics analysis","volume":"11","author":"Sabaie","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ncrna.2023.04.001_bib96","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.omtn.2020.01.005","article-title":"Identification of the regulatory role of lncRNA SNHG16 in myasthenia gravis by constructing a competing endogenous RNA network","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.ncrna.2023.04.001_bib97","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/imm.12940","article-title":"Circular RNA expression profile and potential function of hsa_circ_0045272 in systemic lupus erythematosus","volume":"155","author":"Li","year":"2018","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.ncrna.2023.04.001_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/biom9060206","article-title":"Differential plasma expression profiles of long non-coding RNAs reveal potential biomarkers for systemic lupus erythematosus","volume":"9","author":"Wu","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.ncrna.2023.04.001_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.770679","article-title":"Long non-coding RNA- associated competing endogenous RNA axes in T-cells in multiple sclerosis","volume":"12","author":"Sabaie","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ncrna.2023.04.001_bib100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.exer.2015.02.007","article-title":"Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy","volume":"142","author":"Dik","year":"2016","journal-title":"Exp. Eye Res."},{"issue":"4","key":"10.1016\/j.ncrna.2023.04.001_bib101","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s40618-018-0943-8","article-title":"Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' disease and Graves' orbitopathy","volume":"42","author":"Marin\u00f2","year":"2019","journal-title":"J. Endocrinol. Invest."},{"issue":"2","key":"10.1016\/j.ncrna.2023.04.001_bib102","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.4049\/jimmunol.175.2.1310","article-title":"IL-1 beta induces IL-6 expression in human orbital fibroblasts: identification of an anatomic-site specific phenotypic attribute relevant to thyroid-associated ophthalmopathy","volume":"175","author":"Chen","year":"2005","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.ncrna.2023.04.001_bib103","doi-asserted-by":"crossref","first-page":"C707","DOI":"10.1152\/ajpcell.1998.274.3.C707","article-title":"Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production","volume":"274","author":"Sempowski","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"7","key":"10.1016\/j.ncrna.2023.04.001_bib104","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.4049\/jimmunol.164.7.3806","article-title":"Cultured human fibroblasts express constitutive IL-16 mRNA: cytokine induction of active IL-16 protein synthesis through a caspase-3-dependent mechanism","volume":"164","author":"Sciaky","year":"2000","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.ncrna.2023.04.001_bib105","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ncrna.2023.04.001_bib106","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1167\/iovs.14-14002","article-title":"Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy","volume":"55","author":"Wang","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.ncrna.2023.04.001_bib107","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1089\/thy.2007.0407","article-title":"Immune mechanisms in thyroid eye disease","volume":"18","author":"Lehmann","year":"2008","journal-title":"Thyroid"},{"issue":"10","key":"10.1016\/j.ncrna.2023.04.001_bib108","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1002\/jcb.29712","article-title":"Long noncoding RNA PRKCQ-AS1 promotes CRC cell proliferation and migration via modulating miR-1287-5p\/YBX1 axis","volume":"121","author":"Cui","year":"2020","journal-title":"J. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.ncrna.2023.04.001_bib109","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.bcp.2014.03.010","article-title":"Transforming growth factor alpha promotes osteosarcoma metastasis by ICAM-1 and PI3K\/Akt signaling pathway","volume":"89","author":"Hou","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.ncrna.2023.04.001_bib110","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/nep.13394","article-title":"LncRNA HOTAIR promotes renal interstitial fibrosis by regulating Notch1 pathway via the modulation of miR-124","volume":"24","author":"Zhou","year":"2019","journal-title":"Nephrology"},{"issue":"6","key":"10.1016\/j.ncrna.2023.04.001_bib111","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1007\/s10620-019-5462-8","article-title":"Rosiglitazone inhibits activation of hepatic stellate cells via up-regulating micro-RNA-124-3p to alleviate hepatic fibrosis","volume":"64","author":"Zhi","year":"2019","journal-title":"Dig. Dis. Sci."},{"issue":"11","key":"10.1016\/j.ncrna.2023.04.001_bib112","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1021\/acs.chemrestox.9b00194","article-title":"MiR-326 inhibits inflammation and promotes autophagy in silica-induced pulmonary fibrosis through targeting TNFSF14 and PTBP1","volume":"32","author":"Xu","year":"2019","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ncrna.2023.04.001_bib113","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.12659\/MSM.910000","article-title":"Long noncoding RNA (lncRNA) n379519 promotes cardiac fibrosis in post-infarct myocardium by targeting miR-30","volume":"24","author":"Wang","year":"2018","journal-title":"Med. Sci. Mon."},{"issue":"2","key":"10.1016\/j.ncrna.2023.04.001_bib114","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12020-018-1688-z","article-title":"LncRNAs and miRs as epigenetic signatures in diabetic cardiac fibrosis: new advances and perspectives","volume":"62","author":"Tao","year":"2018","journal-title":"Endocrine"},{"issue":"13","key":"10.1016\/j.ncrna.2023.04.001_bib115","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1158\/0008-5472.CAN-16-3199","article-title":"CXCL1 is critical for premetastatic niche formation and metastasis in colorectal cancer","volume":"77","author":"Wang","year":"2017","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.ncrna.2023.04.001_bib116","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/eurheartj\/ehy085","article-title":"CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration","volume":"39","author":"Wang","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ncrna.2023.04.001_bib117","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3389\/fmicb.2017.01719","article-title":"FPR2: a novel promising target for the treatment of influenza","volume":"8","author":"Alessi","year":"2017","journal-title":"Front. Microbiol."},{"issue":"25","key":"10.1016\/j.ncrna.2023.04.001_bib118","doi-asserted-by":"crossref","first-page":"14354","DOI":"10.1073\/pnas.1918163117","article-title":"Myeloid ALX\/FPR2 regulates vascularization following tissue injury","volume":"117","author":"Sansbury","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.ncrna.2023.04.001_bib119","first-page":"575","article-title":"Gene co-expression analysis for functional classification and gene\u2013disease predictions","volume":"19","author":"van Dam","year":"2017","journal-title":"Briefings Bioinf."},{"issue":"5","key":"10.1016\/j.ncrna.2023.04.001_bib120","first-page":"911","article-title":"CD4+ T cells and the Th1\/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy","volume":"17","author":"Xia","year":"2006","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.ncrna.2023.04.001_bib121","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1210\/jc.2010-1424","article-title":"Regulatory T-cells in Graves' orbitopathy: baseline findings and immunomodulation by anti-T lymphocyte globulin","volume":"96","author":"Kahaly","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.ncrna.2023.04.001_bib122","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00417-012-2092-7","article-title":"Increased serum interleukin-17 in Graves' ophthalmopathy","volume":"250","author":"Kim","year":"2012","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"1","key":"10.1016\/j.ncrna.2023.04.001_bib123","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0167-5699(95)80068-9","article-title":"Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases","volume":"16","author":"Liblau","year":"1995","journal-title":"Immunol. Today"},{"issue":"1","key":"10.1016\/j.ncrna.2023.04.001_bib124","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/eji.201444667","article-title":"MicroRNA-146a controls Th1-cell differentiation of human CD4+ T lymphocytes by targeting PRKC\u03b5","volume":"45","author":"M\u00f6hnle","year":"2015","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.ncrna.2023.04.001_bib125","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.4049\/jimmunol.180.8.5689","article-title":"Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells","volume":"180","author":"Perry","year":"2008","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.ncrna.2023.04.001_bib126","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1159\/000374002","article-title":"Aberrant expression of miRNA and mRNAs in lesioned tissues of graves' disease","volume":"35","author":"Qin","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"3","key":"10.1016\/j.ncrna.2023.04.001_bib127","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1210\/jc.2017-02318","article-title":"A MicroRNA signature for evaluation of risk and severity of autoimmune thyroid diseases","volume":"103","author":"Mart\u00ednez-Hern\u00e1ndez","year":"2018","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"12","key":"10.1016\/j.ncrna.2023.04.001_bib128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014302","article-title":"Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus","volume":"5","author":"Dai","year":"2010","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ncrna.2023.04.001_bib129","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/ncb1201-1124","article-title":"The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling","volume":"3","author":"Virolle","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ncrna.2023.04.001_bib130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fimmu.2012.00151","article-title":"Regulation of T cell homeostasis and responses by pten","volume":"3","author":"Newton","year":"2012","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.ncrna.2023.04.001_bib131","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1089\/thy.2015.0254","article-title":"Forkhead transcription factor FOXO1 is regulated by both a stimulatory thyrotropin receptor antibody and insulin-like growth factor-1 in orbital fibroblasts from patients with graves' ophthalmopathy","volume":"25","author":"Kumar","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.ncrna.2023.04.001_bib132","first-page":"87","article-title":"The interaction of hyaluronate with the cell surface: the hyaluronate receptor and the core protein","volume":"143","author":"Underhill","year":"1989","journal-title":"Ciba Found. Symp."},{"issue":"7","key":"10.1016\/j.ncrna.2023.04.001_bib133","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1167\/iovs.08-2443","article-title":"Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy","volume":"50","author":"van Steensel","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ncrna.2023.04.001_bib134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexmp.2018.11.004","article-title":"Molecular biomarkers of Graves' ophthalmopathy","volume":"106","author":"Longo","year":"2019","journal-title":"Exp. Mol. Pathol."},{"issue":"2","key":"10.1016\/j.ncrna.2023.04.001_bib135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"issue":"7","key":"10.1016\/j.ncrna.2023.04.001_bib136","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000610","article-title":"MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?","volume":"2","author":"Sonkoly","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.ncrna.2023.04.001_bib137","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.2147\/IJN.S82587","article-title":"Delivery of microRNA-146a with polyethylenimine nanoparticles inhibits renal fibrosis in vivo","volume":"10","author":"Morishita","year":"2015","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.ncrna.2023.04.001_bib138","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1582-4934.2008.00556.x","article-title":"miR-21: a small multi-faceted RNA","volume":"13","author":"Krichevsky","year":"2009","journal-title":"J. Cell Mol. Med."},{"issue":"3","key":"10.1016\/j.ncrna.2023.04.001_bib139","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbrc.2009.08.044","article-title":"MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells","volume":"388","author":"Yao","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.ncrna.2023.04.001_bib140","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1158\/1078-0432.CCR-08-2545","article-title":"MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma","volume":"15","author":"Hiyoshi","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"14","key":"10.1016\/j.ncrna.2023.04.001_bib141","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.1158\/0008-5472.CAN-05-0137","article-title":"MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells","volume":"65","author":"Chan","year":"2005","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.ncrna.2023.04.001_bib142","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1084\/jem.20100035","article-title":"miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis","volume":"207","author":"Liu","year":"2010","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.ncrna.2023.04.001_bib143","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1681\/ASN.2010111168","article-title":"Smad3-mediated upregulation of miR-21 promotes renal fibrosis","volume":"22","author":"Zhong","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.ncrna.2023.04.001_bib144","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00395-012-0278-0","article-title":"Role of miR-21 in the pathogenesis of atrial fibrosis","volume":"107","author":"Adam","year":"2012","journal-title":"Basic Res. Cardiol."},{"issue":"6","key":"10.1016\/j.ncrna.2023.04.001_bib145","doi-asserted-by":"crossref","first-page":"A701","DOI":"10.1055\/s-0032-1315533","article-title":"Role of microRNA-21 in right ventricular hypertrophy and fibrosis","volume":"66","author":"Neumann","year":"2012","journal-title":"Pneumologie"},{"issue":"1","key":"10.1016\/j.ncrna.2023.04.001_bib146","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1172\/JCI93557","article-title":"Extracellular matrix as a driver of progressive fibrosis","volume":"128","author":"Herrera","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.ncrna.2023.04.001_bib147","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/thy.2007.0315","article-title":"Consensus statement of the European group on graves' orbitopathy (EUGOGO) on management of graves' orbitopathy","volume":"18","year":"2008","journal-title":"Thyroid"},{"issue":"8","key":"10.1016\/j.ncrna.2023.04.001_bib148","first-page":"3562","article-title":"Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe graves' ophthalmopathy: results of a prospective, single-blind, randomized study","volume":"86","author":"Marcocci","year":"2001","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"4","key":"10.1016\/j.ncrna.2023.04.001_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2011.11.017","article-title":"Transcriptional regulation of miR-224 upregulated in human HCCs by NF\u03baB inflammatory pathways","volume":"56","author":"Scisciani","year":"2012","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.ncrna.2023.04.001_bib150","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/jgh.12523","article-title":"Serum microRNA levels in patients with Crohn's disease during induction therapy by infliximab","volume":"29","author":"Fujioka","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.ncrna.2023.04.001_bib151","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jaapos.2012.03.004","article-title":"Central retinal artery occlusion in Crohn disease","volume":"16","author":"Falavarjani","year":"2012","journal-title":"J. Am. Assoc. Pediatr. Ophthalmol. Strabismus"},{"issue":"10","key":"10.1016\/j.ncrna.2023.04.001_bib152","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00277-014-2111-3","article-title":"Serum microRNA expression profiling predict response to R-CHOP treatment in diffuse large B cell lymphoma patients","volume":"93","author":"Song","year":"2014","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.ncrna.2023.04.001_bib153","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ajo.2019.07.021","article-title":"A new era in the treatment of thyroid eye disease","volume":"208","author":"Patel","year":"2019","journal-title":"Am. J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.ncrna.2023.04.001_bib154","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/ICU.0b013e3283131557","article-title":"The eye and thyroid disease","volume":"19","author":"Kuriyan","year":"2008","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"3","key":"10.1016\/j.ncrna.2023.04.001_bib155","doi-asserted-by":"crossref","first-page":"C672","DOI":"10.1152\/ajpcell.00451.2009","article-title":"Novel anti-adipogenic activity produced by human fibroblasts","volume":"299","author":"Lehmann","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"2","key":"10.1016\/j.ncrna.2023.04.001_bib156","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/1521-4141(200202)32:2<477::AID-IMMU477>3.0.CO;2-U","article-title":"Fibroblast subsets in the human orbit: Thy\u20101+ and Thy\u20101\u2010subpopulations exhibit distinct phenotypes","volume":"32","author":"Koumas","year":"2002","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.ncrna.2023.04.001_bib157","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1167\/iovs.13-12741","article-title":"Orbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype","volume":"54","author":"Kuriyan","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.ncrna.2023.04.001_bib158","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2353\/ajpath.2006.060434","article-title":"Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes","volume":"169","author":"Feldon","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/j.ncrna.2023.04.001_bib159","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006763","article-title":"MicroRNA-130a, a potential antifibrotic target in cardiac fibrosis","volume":"6","author":"Li","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"26","key":"10.1016\/j.ncrna.2023.04.001_bib160","doi-asserted-by":"crossref","first-page":"40830","DOI":"10.18632\/oncotarget.8518","article-title":"Adipogenic miRNA and meta-signature miRNAs involved in human adipocyte differentiation and obesity","volume":"7","author":"Shi","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ncrna.2023.04.001_bib161","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/0022034511425045","article-title":"MicroRNA modulation in obesity and periodontitis","volume":"91","author":"Perri","year":"2012","journal-title":"J. Dent. Res."},{"issue":"10","key":"10.1016\/j.ncrna.2023.04.001_bib162","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1177\/0003319716638242","article-title":"Circulating miR-130a, miR-27b, and miR-210 in patients with peripheral artery disease and their potential relationship with oxidative stress","volume":"67","author":"Signorelli","year":"2016","journal-title":"Angiology"},{"issue":"4","key":"10.1016\/j.ncrna.2023.04.001_bib163","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1128\/MCB.00894-10","article-title":"miR-130 suppresses adipogenesis by inhibiting peroxisome proliferator-activated receptor gamma expression","volume":"31","author":"Lee","year":"2011","journal-title":"Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.ncrna.2023.04.001_bib164","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/MOL.0b013e3283428d9d","article-title":"MicroRNAs in lipid metabolism","volume":"22","author":"Fern\u00e1ndez-Hernando","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"issue":"2","key":"10.1016\/j.ncrna.2023.04.001_bib165","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbrc.2009.09.098","article-title":"microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma","volume":"390","author":"Karbiener","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.ncrna.2023.04.001_bib166","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbrc.2010.01.012","article-title":"miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression","volume":"392","author":"Kim","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Suppl 1","key":"10.1016\/j.ncrna.2023.04.001_bib167","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000509615","article-title":"Oxidative stress in graves disease and graves orbitopathy","volume":"9","author":"Lanzolla","year":"2020","journal-title":"Eur. Thyroid J."},{"issue":"10","key":"10.1016\/j.ncrna.2023.04.001_bib168","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1161\/ATVBAHA.118.311145","article-title":"MicroRNA-199a-3p and MicroRNA-199a-5p take part to a redundant network of regulation of the NOS (NO synthase)\/NO pathway in the endothelium","volume":"38","author":"Joris","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ncrna.2023.04.001_bib169","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mce.2018.05.005","article-title":"miR-199a-3p regulates brown adipocyte differentiation through mTOR signaling pathway","volume":"476","author":"Gao","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"issue":"5","key":"10.1016\/j.ncrna.2023.04.001_bib170","doi-asserted-by":"crossref","first-page":"8526","DOI":"10.3390\/ijms15058526","article-title":"MicroRNA-199a-5p affects porcine preadipocyte proliferation and differentiation","volume":"15","author":"Shi","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ncrna.2023.04.001_bib171","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.18632\/oncotarget.1830","article-title":"miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma","volume":"5","author":"Minna","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ncrna.2023.04.001_bib172","first-page":"1210","article-title":"Microrna-199a-5p functions as a tumor suppressor via suppressing connective tissue growth factor (CTGF) in follicular thyroid carcinoma","volume":"22","author":"Sun","year":"2016","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res. : Int. Med. J. Exp. Clin. Res."},{"issue":"4","key":"10.1016\/j.ncrna.2023.04.001_bib173","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cytogfr.2004.03.006","article-title":"Regulation of PDGF and its receptors in fibrotic diseases","volume":"15","author":"Bonner","year":"2004","journal-title":"Cytokine Growth Factor Rev."},{"issue":"3","key":"10.1016\/j.ncrna.2023.04.001_bib174","doi-asserted-by":"crossref","first-page":"E400","DOI":"10.1210\/jc.2011-2697","article-title":"Orbit-infiltrating mast cells, monocytes, and macrophages produce PDGF isoforms that orchestrate orbital fibroblast activation in Graves' ophthalmopathy","volume":"97","author":"van Steensel","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ncrna.2023.04.001_bib175","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1042\/BC20080191","article-title":"The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation","volume":"101","author":"Lankat-Buttgereit","year":"2009","journal-title":"Biol. Cell."},{"issue":"2","key":"10.1016\/j.ncrna.2023.04.001_bib176","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ni.1828","article-title":"Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21","volume":"11","author":"Sheedy","year":"2010","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.ncrna.2023.04.001_bib177","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1271\/bbb.90892","article-title":"Inhibition by genistein of the lipopolysaccharide-induced down-regulation of programmed cell death 4 in RAW 264.7 mouse macrophages","volume":"74","author":"Yasuda","year":"2010","journal-title":"Biosci., Biotechnol., Biochem."},{"issue":"10","key":"10.1016\/j.ncrna.2023.04.001_bib178","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/carcin\/bgr131","article-title":"Inflammation-induced loss of Pdcd4 is mediated by phosphorylation-dependent degradation","volume":"32","author":"Schmid","year":"2011","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.ncrna.2023.04.001_bib179","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/mi.10.2.5","article-title":"Have tumor suppressor PDCD4 and its counteragent oncogenic miR-21 gone rogue?","volume":"10","author":"Young","year":"2010","journal-title":"Mol. Interv."},{"issue":"5","key":"10.1016\/j.ncrna.2023.04.001_bib180","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1158\/0008-5472.CAN-07-1719","article-title":"Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion","volume":"68","author":"Schmid","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ncrna.2023.04.001_bib181","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fendo.2019.00019","article-title":"Editorial: TSH receptor and autoimmunity","volume":"10","author":"Davies","year":"2019","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.ncrna.2023.04.001_bib182","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/ICU.0b013e3283131557","article-title":"The eye and thyroid disease","volume":"19","author":"Kuriyan","year":"2008","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"4","key":"10.1016\/j.ncrna.2023.04.001_bib183","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1586\/17446651.3.4.473","article-title":"Thyroid-stimulating hormone\/cAMP-mediated proliferation in thyrocytes","volume":"3","author":"Garc\u00eda-Jim\u00e9nez","year":"2008","journal-title":"Expet Rev. Endocrinol. Metabol."},{"issue":"2","key":"10.1016\/j.ncrna.2023.04.001_bib184","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.autrev.2009.03.012","article-title":"TSH receptor autoantibodies","volume":"9","author":"Michalek","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ncrna.2023.04.001_bib185","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.biopha.2017.03.105","article-title":"MiR-155 promotes cell proliferation and inhibits apoptosis by PTEN signaling pathway in the psoriasis","volume":"90","author":"Xu","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.ncrna.2023.04.001_bib186","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1084\/jem.20072108","article-title":"Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder","volume":"205","author":"O'Connell","year":"2008","journal-title":"J. Exp. Med."},{"issue":"17","key":"10.1016\/j.ncrna.2023.04.001_bib187","doi-asserted-by":"crossref","first-page":"28028","DOI":"10.18632\/oncotarget.15885","article-title":"miR-146a and miR-146b promote proliferation, migration and invasion of follicular thyroid carcinoma via inhibition of ST8SIA4","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.ncrna.2023.04.001_bib188","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1210\/jc.2005-0148","article-title":"Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy","volume":"90","author":"Kahaly","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ncrna.2023.04.001_bib189","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jc.2010-1962","article-title":"Clinical review: intravenous glucocorticoids for Graves' orbitopathy: efficacy and morbidity","volume":"96","author":"Zang","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.ncrna.2023.04.001_bib190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002196","article-title":"Immunotherapy in the precision medicine era: melanoma and beyond","volume":"13","author":"Su","year":"2016","journal-title":"PLoS Med."},{"issue":"4","key":"10.1016\/j.ncrna.2023.04.001_bib191","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.molimm.2012.02.001","article-title":"Importance of RNA isolation methods for analysis of exosomal RNA: evaluation of different methods","volume":"50","author":"Eldh","year":"2012","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.ncrna.2023.04.001_bib192","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jcmm.12236","article-title":"Methodological challenges in utilizing mi RNA s as circulating biomarkers","volume":"18","author":"Moldovan","year":"2014","journal-title":"J. Cell Mol. Med."}],"container-title":["Non-coding RNA Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054023000240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054023000240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T04:33:12Z","timestamp":1762835592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468054023000240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":192,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2468054023000240"],"URL":"https:\/\/doi.org\/10.1016\/j.ncrna.2023.04.001","relation":{},"ISSN":["2468-0540"],"issn-type":[{"value":"2468-0540","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-coding RNA-mediated epigenetic alterations in Grave's ophthalmopathy: A scoping systematic review","name":"articletitle","label":"Article Title"},{"value":"Non-coding RNA Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncrna.2023.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}